Schistosomiasis: Why Controlling This Disease Remains a Global Challenge
- Video
27 March 2025
Schistosomiasis: Why Controlling This Disease Remains a Global Challenge
Professor Russell Stothard, Dr Dora Buonfrate, and colleagues have just published The Lancet Group’s latest landmark seminar paper on the disease, providing the most comprehensive review of nearly two decades of research.
These papers are updated just once a decade, making this the definitive resource on schistosomiasis for years to come.
Read the full paper by visiting https://lstm.ac/Schistosomiasis
The Lancet Seminar series gets updated every decade, and it brings forward the most recent advances in policy changes with regard to the Hugs project. Some of the findings are trying to change the way in which we prioritize control to look forward towards elimination of this disease in the next decade.
The strength of this article is it takes a broad view of what SHI is. So it looks at the basic biology, some of the fascinating adaptations of the schism to prioritize the human host as well as livestock, but more importantly, the medical aspects of how we wish to control it in terms of clinical disease as well as public health control.
Our Lancet Seminar article synthesizes the case of research on this topic and offers vital insight into detection, treatment, and future control strategies. With better diagnostic methods and clinical management guidelines, we can improve individual disease management and tailor interventions to ensure effective treatment for all people who need it wherever they are.
The nice thing about this article, it brings together five authors, including myself. Dora born Fran. He was also A-D-T-M-H graduate from the Liverpool School of Tropical Medicine, but we’ve also got Federico from Italy as well as two other colleagues from Gabon and Brazil, which bring together. Lots of global expertise.
The Lancet Seminar series on Human Sister Masters is really the go-to article for those interested in learning about the disease, the specifics, as well as the generics of the disease to help understand what the, um, infection means for those who are obliged by it.
And we have captured all these insights in our Lancet Seminar article.
If you work on neglected tropical disease, this is a publication you cannot afford to miss.
The Lancet Seminar series gets updated every decade, and it brings forward the most recent advances in policy changes with regard to the Hugs project. Some of the findings are trying to change the way in which we prioritize control to look forward towards elimination of this disease in the next decade.
The strength of this article is it takes a broad view of what SHI is. So it looks at the basic biology, some of the fascinating adaptations of the schism to prioritize the human host as well as livestock, but more importantly, the medical aspects of how we wish to control it in terms of clinical disease as well as public health control.
Our Lancet Seminar article synthesizes the case of research on this topic and offers vital insight into detection, treatment, and future control strategies. With better diagnostic methods and clinical management guidelines, we can improve individual disease management and tailor interventions to ensure effective treatment for all people who need it wherever they are.
The nice thing about this article, it brings together five authors, including myself. Dora born Fran. He was also A-D-T-M-H graduate from the Liverpool School of Tropical Medicine, but we’ve also got Federico from Italy as well as two other colleagues from Gabon and Brazil, which bring together. Lots of global expertise.
The Lancet Seminar series on Human Sister Masters is really the go-to article for those interested in learning about the disease, the specifics, as well as the generics of the disease to help understand what the, um, infection means for those who are obliged by it. And we have captured all these insights in our Lancet Seminar article.
If you work on neglected tropical disease, this is a publication you cannot afford to miss.